CY1114144T1 - INHALATED AZRONEONAM FOR THE TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS - Google Patents

INHALATED AZRONEONAM FOR THE TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS

Info

Publication number
CY1114144T1
CY1114144T1 CY20131100596T CY131100596T CY1114144T1 CY 1114144 T1 CY1114144 T1 CY 1114144T1 CY 20131100596 T CY20131100596 T CY 20131100596T CY 131100596 T CY131100596 T CY 131100596T CY 1114144 T1 CY1114144 T1 CY 1114144T1
Authority
CY
Cyprus
Prior art keywords
treatment
bacterial infections
azroneonam
inhalated
prevention
Prior art date
Application number
CY20131100596T
Other languages
Greek (el)
Inventor
Alan Bruce Montgomery
Original Assignee
Gilead Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10010411.6A external-priority patent/EP2301524B1/en
Application filed by Gilead Sciences, Inc. filed Critical Gilead Sciences, Inc.
Publication of CY1114144T1 publication Critical patent/CY1114144T1/en

Links

Abstract

Μέθοδος και σύνθεση για τη θεραπεία πνευμονικών βακτηριακών λοιμώξεων που προκαλούνται από gram αρνητικά βακτήρια, κατάλληλη για τη θεραπεία λοιμώξεων που προκαλούνται από Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenza, Proteus mirabilis, είδη Enterobacter, Serratia marcescens, καθώς και εκείνων που προκαλούνται από Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans και ανθεκτική σε πολλά φάρμακα Pseudomonas aeruginosa, με χρήση συμπυκνωμένης τυποποίησης αζτρεονάμης ή φαρμακευτικώς αποδεκτού άλατος της, η οποία χορηγείται ως τυποποίηση αερολύματος ή ξηράς σκόνης.Method and composition for the treatment of pulmonary bacterial infections caused by gram negative bacteria, suitable for the treatment of infections caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Haemophilus influenza, Haemophilus influenza those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans and many drug-resistant Pseudomonas aeruginosa, using a concentrated formulation of aztreonam or a pharmaceutically acceptable salt thereof, which is administered as a formulation.

CY20131100596T 2000-12-27 2013-07-15 INHALATED AZRONEONAM FOR THE TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS CY1114144T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25842300A 2000-12-27 2000-12-27
EP10010411.6A EP2301524B1 (en) 2000-12-27 2001-12-20 Inhalable aztreonam without arginine for treatment and prevention of pulmonary bacterial infections

Publications (1)

Publication Number Publication Date
CY1114144T1 true CY1114144T1 (en) 2016-07-27

Family

ID=58449077

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100596T CY1114144T1 (en) 2000-12-27 2013-07-15 INHALATED AZRONEONAM FOR THE TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS

Country Status (1)

Country Link
CY (1) CY1114144T1 (en)

Similar Documents

Publication Publication Date Title
CY1111571T1 (en) INHALATED AZRONEONAM FOR THE TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
CY1114621T1 (en) INSPECTION OF INHIBITED LYSINIC AZRTEONAMINE FOR THE TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
NO20024772D0 (en) Percyquinnin, process for its preparation and its use as a drug
JP2017510580A5 (en)
ATE556061T1 (en) THERAPEUTIC OR PROPHYLACTIC AGENT AGAINST MULTIPLE SCLEROSIS
BG106158A (en) New use of compounds as antibacterial agents
KR960700054A (en) APPLICATION OF RILUZOLE IN THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES
CY1106137T1 (en) PHARMACEUTICAL COMPOSITION PEPILAMVANOUS LUMIRACOXIB
NO20063277L (en) Pharmaceutical composition of vinflunine intended for parenteral administration, preparation and use thereof
WO2003097575A3 (en) Amino-functional chalcones
DK1383752T3 (en) Deuterated 3-piperidinopropiophenones as well as drugs containing these compounds
JP2004532828A5 (en)
PT1057828E (en) TROVAFLOXACINE SUSPENSION FOR ORAL ADMINISTRATION
ES2133722T3 (en) USE OF SIMPLE OR CONJUGATED DEXTRANS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO PREVENT OR REDUCE THE RISK OF INFECTION OF BACTERIAL PATHOGENIC GERMS.
CY1114144T1 (en) INHALATED AZRONEONAM FOR THE TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
PT1362590E (en) USE OF CILOBRADINE OR OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE TREATMENT OR PREVENTION OF HEART FAILURE
AR040420A1 (en) INHALABLE AZTREONAM FOR THE TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
BR9915161A (en) Vancoresmycin, process for its production and its use as a drug
TNSN06114A1 (en) PHARMACEUTICAL FORMULATIONS, METHODS AND ADMINISTRATION DIAGRAMS FOR THE TREATMENT AND PREVENTION OF ACUTE CORONARY SYNDROMES
BR0307468A (en) Antimicrobial Thiadiazinone Derivatives Useful in the Treatment of Bacterial Infections
BR0210129A (en) Pharmaceutical combination, methods of treating or preventing diabetes and treating insulin resistance syndrome, parts kit, combined product and method of production thereof
BR0100379A (en) Therapeutic use of the synthetic peptide klklllllklk-nh2
AR054219A1 (en) FORMULATION OF INHALABLE AZTREONAM LISINATE FOR THE TREATMENT AND PREVENTION OF BACTERIAL PULMONARY INFECTIONS
NO20035102D0 (en) Use of a gatran for the manufacture of a medicament for the treatment of lung fibrosis